DK0410246T3 - Erythropoeitin (EPO)-peptider og derimod rettede antistoffer. - Google Patents

Erythropoeitin (EPO)-peptider og derimod rettede antistoffer.

Info

Publication number
DK0410246T3
DK0410246T3 DK90113527T DK90113527T DK0410246T3 DK 0410246 T3 DK0410246 T3 DK 0410246T3 DK 90113527 T DK90113527 T DK 90113527T DK 90113527 T DK90113527 T DK 90113527T DK 0410246 T3 DK0410246 T3 DK 0410246T3
Authority
DK
Denmark
Prior art keywords
epo
antibodies
peptides
epitope
relates
Prior art date
Application number
DK90113527T
Other languages
English (en)
Inventor
Mathias Dr Fibi
Werner Dr Stueber
Original Assignee
Dade Behring Marburg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg Gmbh filed Critical Dade Behring Marburg Gmbh
Application granted granted Critical
Publication of DK0410246T3 publication Critical patent/DK0410246T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK90113527T 1989-07-26 1990-07-14 Erythropoeitin (EPO)-peptider og derimod rettede antistoffer. DK0410246T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3924746A DE3924746A1 (de) 1989-07-26 1989-07-26 Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper

Publications (1)

Publication Number Publication Date
DK0410246T3 true DK0410246T3 (da) 1998-08-31

Family

ID=6385895

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90113527T DK0410246T3 (da) 1989-07-26 1990-07-14 Erythropoeitin (EPO)-peptider og derimod rettede antistoffer.

Country Status (13)

Country Link
US (2) US5106954A (da)
EP (1) EP0410246B1 (da)
JP (1) JP3155002B2 (da)
KR (1) KR0175657B1 (da)
AT (1) ATE161577T1 (da)
AU (1) AU648506B2 (da)
CA (1) CA2021912C (da)
DE (2) DE3924746A1 (da)
DK (1) DK0410246T3 (da)
ES (1) ES2111524T3 (da)
GR (1) GR3026096T3 (da)
IE (1) IE902707A1 (da)
PT (1) PT94813B (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6932968B1 (en) * 1989-07-26 2005-08-23 Dade Behring Marburg Gmbh Erythropoietin (EPO) peptides and antibodies directed against these
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB2270695B (en) * 1992-09-18 1996-06-05 Oxford Res Support Co Ltd Antibodies that activate plasminogen in the manner of streptokinase
US5830851A (en) * 1993-11-19 1998-11-03 Affymax Technologies N.V. Methods of administering peptides that bind to the erythropoietin receptor
US5773569A (en) * 1993-11-19 1998-06-30 Affymax Technologies N.V. Compounds and peptides that bind to the erythropoietin receptor
JP4050314B2 (ja) * 1995-06-07 2008-02-20 オーソ ファーマシューティカル コーポレイション エリトロポエチン受容体に結合する化合物およびペプチド
KR100400637B1 (ko) * 1996-02-06 2004-03-10 씨제이 주식회사 생물학적으로유용한펩타이드
US5952226A (en) * 1996-11-05 1999-09-14 Modex Therapeutiques Hypoxia responsive EPO producing cells
CA2309810C (en) * 1997-12-03 2014-07-08 Roche Diagnostics Gmbh Erythropoietin with high specific activity
KR100524041B1 (ko) * 1999-05-07 2005-10-27 제넨테크, 인크. 신규 침팬지 에리쓰로포이에틴 (chepo) 폴리펩티드 및 이를 코딩하는 핵산
US6831060B2 (en) 1999-05-07 2004-12-14 Genentech, Inc. Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
IL145785A0 (en) * 1999-05-07 2002-07-25 Genentech Inc Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
US6703480B1 (en) 1999-11-24 2004-03-09 Palani Balu Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use
JP2004533596A (ja) * 2000-04-05 2004-11-04 リー，ジョン・ワイ エリスロポエチンおよびエリスロポエチン受容体の検出
CA2405709A1 (en) * 2000-04-12 2001-10-25 Human Genome Sciences, Inc. Albumin fusion proteins
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
CA2437272A1 (en) * 2001-02-06 2002-08-15 Merck Patent Gesellschaft Mit Beschraenkter Haftung Modified erythropoietin (epo) with reduced immunogenicity
US7300916B2 (en) * 2001-02-27 2007-11-27 Yoshiko Yasuda Preventives/remedies for thickened scar, keloid or chronic arthritic diseases
US20030143191A1 (en) * 2001-05-25 2003-07-31 Adam Bell Chemokine beta-1 fusion proteins
JP4991088B2 (ja) * 2001-07-26 2012-08-01 タグラ バイオテクノロジーズ リミテッド アスコルビン酸−３リン酸の安定化誘導体
US6930086B2 (en) 2001-09-25 2005-08-16 Hoffmann-La Roche Inc. Diglycosylated erythropoietin
WO2004099231A2 (en) 2003-04-09 2004-11-18 Neose Technologies, Inc. Glycopegylation methods and proteins/peptides produced by the methods
EP1463752A4 (en) * 2001-12-21 2005-07-13 Human Genome Sciences Inc ALBUMIN FUSION PROTEINS
CA2471363C (en) * 2001-12-21 2014-02-11 Human Genome Sciences, Inc. Albumin fusion proteins
EP1527094B1 (en) * 2002-08-09 2008-07-16 MERCK PATENT GmbH T-cell epitopes in erythropoietin
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
US20070184519A1 (en) * 2003-04-02 2007-08-09 Shabnam Tangri Peptides, polypeptides, and proteins of reduced immunogenicity and methods for their production
US20040266993A1 (en) * 2003-06-30 2004-12-30 Evans Glen A. Non-immunoglobulin binding polypeptides
US7588745B2 (en) * 2004-04-13 2009-09-15 Si Options, Llc Silicon-containing products
US20050255112A1 (en) * 2004-05-17 2005-11-17 Lee Jong Y Compositions and methods for preventing erythropoietin-associated hypertension
WO2009100255A2 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses
EA200701031A1 (ru) * 2004-11-10 2007-10-26 Аплаген Гмбх Молекулы, способствующие гематопоэзу
US7589063B2 (en) * 2004-12-14 2009-09-15 Aplagen Gmbh Molecules which promote hematopoiesis
WO2006050959A2 (en) * 2004-11-10 2006-05-18 Aplagen Gmbh Molecules which promote hematopoiesis
EP1848461A2 (en) * 2005-02-16 2007-10-31 Nektar Therapeutics Al, Corporation Conjugates of an epo moiety and a polymer
WO2006119767A2 (en) 2005-05-10 2006-11-16 Elisabeth Bock Neuritogenic peptides
EP1736481A1 (en) * 2005-05-13 2006-12-27 Charite Universitätsmedizin-Berlin Erythropoietin variants
EA200800109A1 (ru) * 2005-06-23 2008-06-30 Аплаген Гмбх Суправалентные соединения
EP2540309B1 (en) 2005-08-05 2017-11-22 Araim Pharmaceuticals, Inc. Tissue protective peptides and uses thereof
MX2008011389A (es) * 2006-03-09 2009-01-26 Aplagen Gmbh Moleculas modificadas las cuales promueven hematopoyesis.
EP2134862A4 (en) * 2007-03-12 2011-04-20 Univ Utah Res Found COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF DIABETIC MICROVASCULAR COMPLICATIONS
KR20180123731A (ko) * 2008-01-22 2018-11-19 아라임 파마슈티칼즈, 인크. 조직 손상 관련 질환 및 장애를 예방 및 치료하기 위한 조직 보호 펩티드 및 펩티드 유사체
CN107022020A (zh) 2008-09-26 2017-08-08 Ambrx公司 修饰的动物促红细胞生成素多肽和其用途
JP6306605B2 (ja) * 2012-12-05 2018-04-04 ノバルティス アーゲー Ｅｐｏを標的とする抗体のための組成物および方法
ES2913530T3 (es) 2015-08-12 2022-06-02 Novartis Ag Métodos para tratar trastornos oftálmicos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56145222A (en) * 1980-04-28 1981-11-11 Toshiyuki Hamaoka Improved antibody and its preparation
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
US4558005A (en) * 1982-09-13 1985-12-10 University Patents, Inc. Monoclonal anti-erythropoietin
US4558006A (en) * 1983-02-04 1985-12-10 Kirin-Amgen, Inc. A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
US4677195A (en) * 1985-01-11 1987-06-30 Genetics Institute, Inc. Method for the purification of erythropoietin and erythropoietin compositions

Also Published As

Publication number Publication date
ATE161577T1 (de) 1998-01-15
IE902707A1 (en) 1991-02-27
ES2111524T3 (es) 1998-03-16
EP0410246A1 (de) 1991-01-30
CA2021912C (en) 2001-11-27
JPH0381294A (ja) 1991-04-05
GR3026096T3 (en) 1998-05-29
DE3924746A1 (de) 1991-01-31
CA2021912A1 (en) 1991-01-27
PT94813B (pt) 1997-04-30
US5712370A (en) 1998-01-27
JP3155002B2 (ja) 2001-04-09
PT94813A (pt) 1991-03-20
US5106954A (en) 1992-04-21
KR910002897A (ko) 1991-02-26
AU5977890A (en) 1991-01-31
KR0175657B1 (ko) 1999-04-01
AU648506B2 (en) 1994-04-28
DE59010787D1 (de) 1998-02-05
EP0410246B1 (de) 1997-12-29

Similar Documents

Publication Publication Date Title
DK0410246T3 (da) Erythropoeitin (EPO)-peptider og derimod rettede antistoffer.
ES2082775T3 (es) Anticuerpos de proteinas latentes de papilomavirus humano, sistemas de diagnostico y procedimientos.
ES2062971T3 (es) Peptidos de la cubierta de htlv iii.
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
EP0413763A4 (en) Method for the production of monoclonal antibodies utilizing a germfree animal
DE69127487D1 (de) Verfahren zum Nachweis der Alzheimer-Krankheit
NO910209D0 (no) Fremgangsmaate for fremstilling av rekombinante humane anti-cd18 antistoffer.
DE3689948T2 (de) Monoklonale antikörper und testverfahren.
DE68903882D1 (de) Immunochemisches testverfahren fuer humanen granulozyten-makrophagen-kolonie stimulierenden faktor.
DE69228739T2 (de) Immunoassay und monoklonaler antikörper zum nachweis von diarrhetischem schalentiergift
DE3785175D1 (de) A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung.
NO974793L (no) Fremgangsmåte til fremstilling av et monoklonalt antistoff mot Onkostatin M, eller et fragment derav
DK0513227T3 (da) Monoklonale antistoffer, der skelner mellem prote iner med nativ og modificeret sekvens
RU96119723A (ru) Способ выявления т-зависимого иммунодефицита
ZA903854B (en) Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
MX9707020A (es) Compuestos y metodos para la deteccion de infeccion por t. cruzi.
NO912192L (no) Rekombinante dna og fremgangsmaate for fremstilling av chimere antistoffer.
DK362087D0 (da) Method for a rapid and sensitive detection of early appearing antibodies against retroviruses, as well as igg antibodies against certain retroviruses
NO890775D0 (no) Apparat for testing av utblaasningssikring.
DK27991D0 (da) Telefon med sensorer for human test, og transmitteret isaer via isdn-net
DE69113923T2 (de) Quantitatives Analysenverfahren und dazugehörendes, mit einem Wegwerffühler versehenes System.
DK630189D0 (da) Fremgangsmaade og diagnosesaet til paavisning af antistoffer samt vandig vaskevaeske til brug herved
NO912050D0 (no) Sensor for optisk undersoekelse.